135 related articles for article (PubMed ID: 2847132)
21. Stereoselective block of cardiac sodium channels by bupivacaine in guinea pig ventricular myocytes.
Valenzuela C; Snyders DJ; Bennett PB; Tamargo J; Hondeghem LM
Circulation; 1995 Nov; 92(10):3014-24. PubMed ID: 7586272
[TBL] [Abstract][Full Text] [Related]
22. Chronotropic and inotropic effects of ropivacaine, bupivacaine, and lidocaine in the spontaneously beating and electrically paced isolated, perfused rabbit heart.
Pitkanen M; Feldman HS; Arthur GR; Covino BG
Reg Anesth; 1992; 17(4):183-92. PubMed ID: 1515382
[TBL] [Abstract][Full Text] [Related]
23. Modification of "depressed fast channel dependent slow conduction" by lidocaine and verapamil in the presence or absence of catecholamines--evidence for alteration of preferential ionic channels for slow conduction.
Arita M; Kiyosue T
Jpn Circ J; 1983 Jan; 47(1):68-81. PubMed ID: 6298480
[TBL] [Abstract][Full Text] [Related]
24. The neuronal lipid membrane permeability was markedly increased by bupivacaine and mildly affected by lidocaine and ropivacaine.
Pardo L; Blanck TJ; Recio-Pinto E
Eur J Pharmacol; 2002 Nov; 455(2-3):81-90. PubMed ID: 12445573
[TBL] [Abstract][Full Text] [Related]
25. Sodium channel-blocking properties of flecainide, a class IC antiarrhythmic drug, in guinea-pig papillary muscles. An open channel blocker or an inactivated channel blocker.
Kojima M; Hamamoto T; Ban T
Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):441-7. PubMed ID: 2544812
[TBL] [Abstract][Full Text] [Related]
26. Electrophysiological effects of SD-3212, a new antiarrhythmic agent with vasodilator action, on guinea-pig ventricular cells.
Kodama I; Suzuki R; Maruyama K; Toyama J
Br J Pharmacol; 1995 Jan; 114(2):503-9. PubMed ID: 7881749
[TBL] [Abstract][Full Text] [Related]
27. Combined effects of rate membrane potential, and drugs on maximum rate of rise (Vmax) of action potential upstroke of guinea pig papillary muscle.
Chen C; Gettes LS
Circ Res; 1976 Jun; 38(6):464-9. PubMed ID: 1269096
[TBL] [Abstract][Full Text] [Related]
28. The electrophysiologic effects of bupivacaine on adult, neonatal, and fetal guinea pig papillary muscles.
Sun LS; Rosen MR
Anesthesiology; 1991 May; 74(5):893-9. PubMed ID: 2021207
[TBL] [Abstract][Full Text] [Related]
29. [Voltage-dependent effects of lidocaine and its metabolite, monoethylglycine xylidide (MEGX), on maximum rate of rise (Vmax) of action potential upstroke in guinea-pig papillary muscles].
Hiraoka I; Oshita S; Itoh M; Sakabe T; Ban T
Masui; 1991 Sep; 40(9):1394-9. PubMed ID: 1942514
[TBL] [Abstract][Full Text] [Related]
30. Effects of the two enantiomers, S-16257-2 and S-16260-2, of a new bradycardic agent on guinea-pig isolated cardiac preparations.
Pérez O; Gay P; Franqueza L; Carrón R; Valenzuela C; Delpón E; Tamargo J
Br J Pharmacol; 1995 Jul; 115(5):787-94. PubMed ID: 8548178
[TBL] [Abstract][Full Text] [Related]
31. Effects of bupivacaine on contraction and membrane potential in isolated canine papillary muscles.
Shibuya N; Momose Y; Ito Y
Pharmacology; 1993 Sep; 47(3):158-66. PubMed ID: 8415866
[TBL] [Abstract][Full Text] [Related]
32. Electromechanical effects of zatebradine on isolated guinea pig cardiac preparations.
Pérez O; Gay P; Franqueza L; Carrón R; Valenzuela C; Delpón E; Tamargo J
J Cardiovasc Pharmacol; 1995 Jul; 26(1):46-54. PubMed ID: 7564364
[TBL] [Abstract][Full Text] [Related]
33. Block of activated and inactivated sodium channels by class-I antiarrhythmic drugs studied by using the maximum upstroke velocity (Vmax) of action potential in guinea-pig cardiac muscles.
Kodama I; Toyama J; Takanaka C; Yamada K
J Mol Cell Cardiol; 1987 Apr; 19(4):367-77. PubMed ID: 2441073
[TBL] [Abstract][Full Text] [Related]
34. Comparison of toxicity effects of ropivacaine, bupivacaine, and lidocaine on rabbit intervertebral disc cells in vitro.
Cai XY; Xiong LM; Yang SH; Shao ZW; Xie M; Gao F; Ding F
Spine J; 2014 Mar; 14(3):483-90. PubMed ID: 23978626
[TBL] [Abstract][Full Text] [Related]
35. Complex blockade of TTX-resistant Na+ currents by lidocaine and bupivacaine reduce firing frequency in DRG neurons.
Scholz A; Kuboyama N; Hempelmann G; Vogel W
J Neurophysiol; 1998 Apr; 79(4):1746-54. PubMed ID: 9535944
[TBL] [Abstract][Full Text] [Related]
36. Functional consequences of lidocaine binding to slow-inactivated sodium channels.
Balser JR; Nuss HB; Romashko DN; Marban E; Tomaselli GF
J Gen Physiol; 1996 May; 107(5):643-58. PubMed ID: 8740377
[TBL] [Abstract][Full Text] [Related]
37. Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs.
Ragsdale DS; Scheuer T; Catterall WA
Mol Pharmacol; 1991 Nov; 40(5):756-65. PubMed ID: 1658608
[TBL] [Abstract][Full Text] [Related]
38. Cocaine concentration-effect relationship in the presence and absence of lidocaine: evidence of competitive binding between cocaine and lidocaine.
Liu D; Hariman RJ; Bauman JL
J Pharmacol Exp Ther; 1996 Feb; 276(2):568-77. PubMed ID: 8632323
[TBL] [Abstract][Full Text] [Related]
39. Use-dependent blocking action of newly developed lidocaine-analogs on maximum rate of rise of action potentials in guinea pig papillary muscle.
Toyama J; Kodama I; Kusunoki T; Ishihara T; Hattori Y; Yamada K
Jpn Heart J; 1987 Mar; 28(2):273-85. PubMed ID: 3110457
[TBL] [Abstract][Full Text] [Related]
40. Electrophysiological properties of a new antiarrhythmic agent, bisaramil on guinea-pig, rabbit and canine cardiac preparations.
Sunami A; Sawanobori T; Adaniya H; Hiraoka M
Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):323-30. PubMed ID: 1961258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]